C-reactive protein uptake by macrophage cell line via class-A scavenger receptor

Clinical Chemistry

Volumn 56, Issue 3, 2010, Pages 478-481

  Fujita, Yoshiko ^a   Kakino, Akemi ^a   Harada Shiba, Mariko ^a   Sato, Yuko ^a   Otsui, Kazunori ^a   Yoshimoto, Ryo ^a   Sawamura, Tatsuya ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHLORDANE; FLUORESCENT DYE; LOW DENSITY LIPOPROTEIN RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN ANTIBODY; SCAVENGER RECEPTOR A; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIUM; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

ANIMALS; C-REACTIVE PROTEIN; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CRICETINAE; DOWN-REGULATION; HUMANS; MACROPHAGES; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, OXIDIZED LDL; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SCAVENGER RECEPTORS, CLASS A;

EID: 77649220443     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.140202     Document Type: Article

References (19)

1. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004;279:48487-90.
2. Volanakis JE, Kaplan MH. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q. J Immunol 1974;113:9-17.
3. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
5. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
6. Sun H, Koike T, Ichikawa T, Hatakeyama K, Shiomi M, Zhang B, et al. C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol 2005;167:1139-48.
7. Khreiss T, Jozsef L, Hossain S, Chan JS, Potempa LA, Filep JG. Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem 2002;277:40775-81.
8. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is Fcgamma receptor II. J Exp Med 1999;190:585-90.
9. Stein MP, Mold C, Du Clos TW. C-reactive protein binding to murine leukocytes requires Fc gamma receptors. J Immunol 2000;164:1514-20.
10. Fujita Y, Kakino A, Nishimichi N, Yamaguchi S, Sato Y, Machida S, et al. Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates its vascular effects. Clin Chem 2009;55:285-94.
11. Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 2006;26:1702-11.
12. Greaves DR, Gordon S. The immune system and atherogenesis: recent insights into the biology of macrophage scavenger receptors. Thematic review series. J Lipid Res 2005;46:11-20.
13. Nishimura N, Harada-Shiba M, Tajima S, Sugano R, Yamamura T, Qiang QZ, Yamamoto A. Acquisition of secretion of transforming growth factorbeta 1 leads to autonomous suppression of scavenger receptor activity in a monocytemacrophage cell line, THP-1. J Biol Chem 1998;273:1562-7.
14. Tebo JM, Mortensen RF. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937. J Immunol 1990;144:231-8.
15. Singh U, Dasu MR, Yancey PG, Afify A, Devaraj S, Jialal I. Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. J Lipid Res 2008;49:1015-23.
16. Fleit HB, Kobasiuk CD. The human monocyte-like cell line THP-1 expresses Fc gamma RI and Fc gamma RII. J Leukoc Biol 1991;49:556-65.
17. Morganelli PM, Kennedy SM, Mitchell TI. Differential effects of interferon-gamma on metabolism of lipoprotein immune complexes mediated by specific human macrophage Fcgamma receptors. J Lipid Res 2000;41:405-15.
18. Geng YJ, Hansson GK. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 1992;89:1322-30.
19. Turk JR, Carroll JA, Laughlin MH, Thomas TR, Casati J, Bowles DK, Sturek M. C-reactive protein correlates with macrophage accumulation in coronary arteries of hypercholesterolemic pigs. J Appl Physiol 2003;95:1301-4.